Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $3.49 billion. The enterprise value is $6.45 billion.
| Market Cap | 3.49B |
| Enterprise Value | 6.45B |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 129.67 million shares outstanding. The number of shares has increased by 1.40% in one year.
| Current Share Class | 129.67M |
| Shares Outstanding | 129.67M |
| Shares Change (YoY) | +1.40% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 67.08% |
| Float | 58.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 110.00 |
| PS Ratio | 1.04 |
| Forward PS | 1.25 |
| PB Ratio | 2.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.23 |
| P/OCF Ratio | 12.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.41, with an EV/FCF ratio of 31.83.
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | 10.41 |
| EV / EBIT | 14.57 |
| EV / FCF | 31.83 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.02.
| Current Ratio | 2.17 |
| Quick Ratio | 1.65 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 4.60 |
| Debt / FCF | 16.34 |
| Interest Coverage | 1.54 |
Financial Efficiency
Return on equity (ROE) is 2.08% and return on invested capital (ROIC) is 5.18%.
| Return on Equity (ROE) | 2.08% |
| Return on Assets (ROA) | 3.69% |
| Return on Invested Capital (ROIC) | 5.18% |
| Return on Capital Employed (ROCE) | 6.76% |
| Weighted Average Cost of Capital (WACC) | 10.81% |
| Revenue Per Employee | $210,006 |
| Profits Per Employee | -$5,438 |
| Employee Count | 16,000 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 30.77 |
Taxes
In the past 12 months, SGRY has paid $18.60 million in taxes.
| Income Tax | 18.60M |
| Effective Tax Rate | 20.83% |
Stock Price Statistics
The stock price has increased by +69.92% in the last 52 weeks. The beta is 1.88, so SGRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | +69.92% |
| 50-Day Moving Average | 17.30 |
| 200-Day Moving Average | 15.09 |
| Relative Strength Index (RSI) | 89.75 |
| Average Volume (20 Days) | 7,693,827 |
Short Selling Information
The latest short interest is 8.95 million, so 6.90% of the outstanding shares have been sold short.
| Short Interest | 8.95M |
| Short Previous Month | 14.33M |
| Short % of Shares Out | 6.90% |
| Short % of Float | 15.25% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, SGRY had revenue of $3.36 billion and -$87.00 million in losses. Loss per share was -$0.68.
| Revenue | 3.36B |
| Gross Profit | 747.60M |
| Operating Income | 442.90M |
| Pretax Income | 89.30M |
| Net Income | -87.00M |
| EBITDA | 620.20M |
| EBIT | 442.90M |
| Loss Per Share | -$0.68 |
Balance Sheet
The company has $354.50 million in cash and $3.31 billion in debt, with a net cash position of -$2.96 billion or -$22.83 per share.
| Cash & Cash Equivalents | 354.50M |
| Total Debt | 3.31B |
| Net Cash | -2.96B |
| Net Cash Per Share | -$22.83 |
| Equity (Book Value) | 3.26B |
| Book Value Per Share | 12.84 |
| Working Capital | 581.40M |
Cash Flow
In the last 12 months, operating cash flow was $277.90 million and capital expenditures -$75.10 million, giving a free cash flow of $202.80 million.
| Operating Cash Flow | 277.90M |
| Capital Expenditures | -75.10M |
| Depreciation & Amortization | 177.30M |
| Net Borrowing | -220.80M |
| Free Cash Flow | 202.80M |
| FCF Per Share | $1.56 |
Margins
Gross margin is 22.25%, with operating and profit margins of 13.18% and -2.59%.
| Gross Margin | 22.25% |
| Operating Margin | 13.18% |
| Pretax Margin | 2.66% |
| Profit Margin | -2.59% |
| EBITDA Margin | 18.46% |
| EBIT Margin | 13.18% |
| FCF Margin | 6.04% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.40% |
| Shareholder Yield | -1.40% |
| Earnings Yield | -2.51% |
| FCF Yield | 5.80% |
Analyst Forecast
The average price target for SGRY is $24.40, which is -9.46% lower than the current price. The consensus rating is "Hold".
| Price Target | $24.40 |
| Price Target Difference | -9.46% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -3.00% |
| EPS Growth Forecast (3Y) | 3.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 0.92 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.92 |
| Piotroski F-Score | 6 |